Föreläsningar och seminarier Keynote-föreläsning (StratNeuro retreat): "How psychedelic neuroscience can revolutionize psychiatry and neurology"
Professor Nutt gästar StratNeuro:s Retreat 2022 och håller en föreläsning den 20 maj 2022 kl. 09:00, som forskare vid KI, som inte deltar vid konferensen, kan ansluta till digitalt. Anmälan sker via länk.
"How psychedelic neuroscience can revolutionize psychiatry and neurology"
David Nutt, Professor, The Edmond J Safra Chair in Neuropsychopharmacology, Department of Brain Sciences, Faculty of Medicine, Imperial College London, UK
"David is currently Chair of DrugScience (formally the Independent Scientific Committee on Drugs (ISCD) and President of the European Brain Council. Previously he has been President of the European College of Neuropsychopharmacology (ECNP), the British Neuroscience Association (BNA) and the British Association of Psychopharmacology (BAP). In addition he is a Fellow of the Royal Colleges of Physicians and of Psychiatrists and a Fellow of the Academy of Medical Sciences. He is also the UK Director of the European Certificate and Masters in Affective Disorders Courses and a member of the International Centre for Science in Drug Policy. He has edited the Journal of Psychopharmacology for over two decades and acts as the psychiatry drugs advisor to the British National Formulary. He has published over 400 original research papers, a similar number of reviews and books chapters, eight government reports on drugs and 27 books.
Previously he has been a member and then Chair of the Advisory Committee on the Misuse of Drugs (ACMD – 1998-2009), a member of the HEFCE/NHS Senior Lecturer Selection Panel and of the MRC Neuroscience Board. Other previous national contributions include serving as the medical expert on the Independent Inquiry into the Misuse of Drugs Act (2000 Runciman report), and membership of the Committee on Safety of Medicines, the Committee on NHS drugs and the Ministry of Defence Science Advisory Board. He was the clinical scientific lead on the 2004/5 UK Government Foresight initiative “Brain science, addiction and drugs” that provided a 25-year vision for this area of science and public policy."
(Text från imperial.ac.uk)
Johan Lundberg, Karolinska Institutet, Institutionen för klinisk neurovetenskap